CMA
64
5
LLY
50
3
MAT
54
3
JNJ
47
-4
CHRW
50
2
IR
77
8
HRL
35
-3
DTE
54
-2
GLW
68
4
XYL
58
6
SEE
41
4
CVX
40
2
STX
59
6
ETR
66
-2
MOS
23
3
EMC
56
11
A
46
3
MAR
53
3
AFL
56
-3
ABBV
53
2
CMA
64
5
LLY
50
3
MAT
54
3
JNJ
47
-4
CHRW
50
2
IR
77
8
HRL
35
-3
DTE
54
-2
GLW
68
4
XYL
58
6
SEE
41
4
CVX
40
2
STX
59
6
ETR
66
-2
MOS
23
3
EMC
56
11
A
46
3
MAR
53
3
AFL
56
-3
ABBV
53
2
Financhill
Back

AquaBounty Technologies 10K Form

Sell
37

AQB
AquaBounty Technologies

Last Price:
1.16
Seasonality Move:
-15.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AQB News And Ratings

See the #1 stock for the next 7 days that we like better than AQB

AQB Financial Statistics

Sales & Book Value

Annual Sales: $2.47M
Cash Flow: $-5.2M
Price / Cash Flow: 0
Annual Sales: $26.73
Price / Book: 0.05

Profitability

EPS (TTM): -19.77000
Net Income (TTM): $-76.24M
Gross Margin: $-12.81M
Return on Equity: -49.2%
Return on Assets: -42.64%

AquaBounty Technologies Earnings Forecast

Key AquaBounty Technologies Financial Ratios

  • The Gross Profit Margin over the past 19 years for AQB is -518.02%.
  • The Selling, General & Administrative Expenses for AQB have been equal to 558.26% of Gross Profit Margin.
  • The Research & Development expenses have been 28.46% of Revenue.
  • The Interest Expense is -1.10% of Operating Income.
  • The Net Earning history of AQB is -1,114.50% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 13 years.

AquaBounty Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AQB
CUSIP: 03842K
Website: aquabounty.com

Debt

Debt-to-Equity Ratio: 0.1
Current Ratio: 1.96
Quick Ratio: 0.04

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AQB Technical Analysis vs Fundamental Analysis

Sell
37
AquaBounty Technologies (AQB) is a Sell

Is AquaBounty Technologies a Buy or a Sell?